MARKET

ADCT

ADCT

Adc Therapeutics Sa
NYSE
1.150
-0.070
-5.74%
After Hours: 1.140 -0.01 -0.87% 19:34 07/24 EDT
OPEN
1.250
PREV CLOSE
1.220
HIGH
1.260
LOW
1.145
VOLUME
725.75K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
0.7796
MARKET CAP
146.27M
P/E (TTM)
-1.0284
1D
5D
1M
3M
1Y
5Y
1D
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
Benzinga · 4d ago
ADC Therapeutics Halts LOTIS-10 Liver-Impairment Study: What It Means for Zynlonta and Investors
TipRanks · 5d ago
Weekly Report: what happened at ADCT last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at ADCT last week (0706-0710)?
Weekly Report · 07/13 09:56
Weekly Report: what happened at ADCT last week (0629-0703)?
Weekly Report · 07/06 09:59
ADC Therapeutics Grants One-Time Retention Awards to Executives
TipRanks · 07/02 21:30
ADC Therapeutics Announces New Employee Inducement Grant
PR Newswire · 07/01 20:05
Analysts Are Bullish on Top Healthcare Stocks: ADC Therapeutics (ADCT), Moleculin Biotech (MBRX)
TipRanks · 07/01 18:20
More
About ADCT
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Webull offers ADC Therapeutics SA stock information, including NYSE: ADCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADCT stock methods without spending real money on the virtual paper trading platform.